KAREN JULIEN: Open Payments
NPI 1134355324 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,375 in 42 payments from 18 companies in 2025. Trend: 2023 $506 · 2024 $1,021 · 2025 $1,375
Food & beverage: $1,375
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $214 |
| Incyte Corporation | 3 | $150 |
| Eisai Inc. | 5 | $143 |
| Astellas Pharma US Inc | 1 | $126 |
| SOBI, INC | 3 | $106 |
| Syndax Pharmaceuticals, Inc. | 1 | $103 |
| Gilead Sciences, Inc. | 3 | $93 |
| GENZYME CORPORATION | 3 | $93 |
| JAZZ PHARMACEUTICALS INC. | 1 | $63 |
| Daiichi Sankyo Inc. | 2 | $51 |
Products named: CALQUENCE, ZYNYZ, Lenvima, Vyloy, Doptelet, Trodelvy, SARCLISA, ZIIHERA.
Industry payments across CA — which companies pay providers there.
